Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 3203 questions Show Answers
To ask the Scottish Government what its position is on (a) workplaces and (b) education providers having policies on (i) menstrual, (ii) perimenopause and (iii) menopause leave.
To ask the Scottish Government what plans it has to ensure that newly qualified teachers are able to secure a post in their own, or a nearby, local authority.
To ask the Scottish Government which (a) clinical networks and (b) stakeholders it is working with to inform the delivery of the new Framework for Pain Management publication.
To ask the Scottish Government, following the reported cancellation of a proposed meeting with patient representatives on 20 June 2022, whether it can confirm that a rescheduled meeting will take place before the publication of the new Framework for Pain Management.
To ask the Scottish Government what protections exist for ancient and veteran trees, and how ancient and veteran trees are recorded for protection purposes.
To ask the Scottish Government what steps it is taking to address any geographical variation in primary care pathways for the early detection of liver disease.
To ask the Scottish Government what plans it has to increase the use of FibroScan and enhanced liver fibrosis (ELF) tests in primary care in order to improve the early diagnosis of liver disease.
To ask the Scottish Government what public health measures it is taking to reduce stigma around liver disease.
To ask the Scottish Government, further to the answer to question S6W-07901 by Maree Todd on 3 May 2022, when it will publish the findings of the public consultation on the draft Framework for Pain Management Service Delivery.
To ask the Scottish Government what recent assessment it has made of the impact of (a) alcohol misuse and (b) obesity on liver disease mortality rates.